How a targeted drug kept one patient alive 15 years — but failed to save her friends

AI Summary

A lung cancer patient describes how a targeted treatment extended her life, while reflecting on the friends who did not survive. She also argues that research should give more attention to survivors' quality of life, not only survival statistics.

A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality of life for survivors — not so much.”